Adynovate 1500 Unit (Antihemophilic Factor (Recombinant), Pegylated KIT) 1500 UNIT

ADYNOVATE 1500 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent complications.

Strength

1500 UNIT

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADYNOVATE 1500 Unit is primarily used for the control and prevention of bleeding episodes in patients with hemophilia B. It works by replacing the missing clotting factor in the blood, which is essential for proper blood coagulation. This medication is often used in situations where there is a risk of bleeding, such as surgery or dental procedures. It is also used for routine prophylaxis to prevent bleeding episodes in individuals with hemophilia B.

Side Effects

Common effects of ADYNOVATE 1500 Unit may include mild reactions at the injection site, such as redness or swelling. Some users might experience headache, nausea, or dizziness. These effects are generally mild and temporary. Severe allergic reactions are rare but require immediate medical attention.

Precautions & Warnings

ADYNOVATE 1500 Unit should be handled with care and stored as directed to maintain its efficacy. It is important to follow the instructions provided by a healthcare professional for proper administration. Patients should be monitored for any signs of allergic reactions or unusual bleeding. This medication should not be used if the solution appears cloudy or contains particles.

Avoid Interactions

ADYNOVATE 1500 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform a healthcare provider about all medications being taken, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the efficacy of this medication. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

ADYNOVATE 1500 Unit is used to control and prevent bleeding episodes in patients with hemophilia B.

ADYNOVATE 1500 Unit is administered intravenously, typically by a healthcare professional.

Common side effects may include mild reactions at the injection site, headache, nausea, or dizziness.

Yes, ADYNOVATE 1500 Unit can be used for routine prophylaxis to prevent bleeding episodes in individuals with hemophilia B.

If you experience an allergic reaction, seek immediate medical attention.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.